Nicolas Villa Guillen, MD
Gastroenterology · Spokane, WANPI 1265696553
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by Boston Scientific at 29.4% of the total. 2025 is the largest year on record at $4,338, 2.6 times the $1,670 reported in 2019. Among gastroenterology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $75.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Cook Medical LLC$3K
- 3-d Matrix, Inc.$2K
- Olympus America Inc.$1K
- Ambu Inc.$972
- AbbVie$491
- plus $3K from 31 others
What the payments were for
- Food & beverage$14,668100%
- Education$300%
- Entertainment$410%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 61 | $4,336 |
| Cook Medical LLC | 35 | $2,717 |
| 3-d Matrix, Inc. | 1 | $1,528 |
| Olympus America Inc. | 12 | $1,303 |
| Ambu Inc. | 4 | $972 |
| AbbVie | 11 | $491 |
| Conmed Corporation | 3 | $414 |
| Braintree Laboratories, Inc. | 5 | $371 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $244 |
| Mauna Kea Technologies, Inc. | 4 | $218 |
| Medtronic | 2 | $215 |
| Regeneron Healthcare Solutions, Inc. | 4 | $198 |
| Merck | 3 | $167 |
| ERBE USA Inc | 1 | $156 |
| Nevro Corp. | 2 | $152 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $124 |
| Merit Medical Systems Inc | 1 | $102 |
| Regeneron | 1 | $102 |
| Janssen Scientific Affairs, LLC | 1 | $98 |
| Omega Medical Imaging, LLC | 1 | $97 |
| Endogastric Solutions, Inc | 1 | $88 |
| Intercept Pharmaceuticals, Inc. | 4 | $76 |
| Pfizer | 2 | $70 |
| Lilly USA, LLC | 3 | $61 |
| Nestle Healthcare Nutrition Inc. | 3 | $61 |
| Johnson & Johnson | 3 | $56 |
| UCB, Inc. | 2 | $43 |
| Amgen | 1 | $42 |
| QOL Medical, LLC | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Ardelyx, Inc. | 1 | $25 |
| Gilead | 1 | $25 |
| Novo Nordisk | 1 | $18 |
| Bristol Myers Squibb | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXALT Model D$574
- EndoClot PHS$417
- CONMED BILIARY$414
- Hemospray$405
- SUFLAVE$331
- Instinct$329
- SPYGLASS$323
- CONMED DILATION$296
- Mavyret$234
- DUPIXENT$225
- CAPTIVATOR COLD$181
- EXALT$180
- SUTAB$174
- GENERAL - THERAPIES$162
- ERBE$156
- AXIOS$154
- VISIGLIDE$150
- Olympus$150
- HANAROSTENT Esophagus TTS(CCC)$142
- Single Use Repositionable Clip$137
How this compares
$14,740 in reported general payments places this provider in the 90th percentile of 447 gastroenterology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 13 | $47,437 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 628 | $10,647 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 107 | $6,796 |
| LinzessLinaclotide | 12 | $6,481 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 23 | $3,736 |
| Pantoprazole Sodium | 228 | $2,508 |
| Sucralfate | 16 | $1,887 |
| Ondansetron OdtOndansetron | 599 | $1,719 |
| Omeprazole | 37 | $491 |
| Famotidine | 37 | $450 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 24 | $369 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 22 | $328 |
| Metronidazole | 12 | $162 |
| Ondansetron Hcl | 20 | $18 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $491 | $53,91725 claims |
| Braintree Laboratories, Inc.Sutab | $371 | $3,73623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 447 gastroenterology providers in Washington.
Other gastroenterology in Spokane
- Eashen LiuSpokane$62K
- Harold PreiksaitisSpokane$50K
- Michael KestellSpokane$22K
- Miguel Ordonez CastellanosSpokane$16K
- Michael ChioreanIssaquah$1.4M
- Kris KowdleySeattle$1.4M
- Venkatachala MohanBellevue$564K
- Scott LeeSeattle$220K
- John SunTacoma$219K
- Klaus MergenerEdmonds$185K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.